[3] Wang is a Fellow of the International Orthopaedic Research (FIOR), and American Institute for Medical and Biological Engineering (AIMBE).
Additionally, he has been awarded research grants from DOD for several projects that aim to develop practical and clinically actionable strategies for the prevention and treatment of tendinopathy.
[5][6] Wang's research team has also worked on the identification and characterization of tendon stem cells (TSCs) in humans, mice, rats, and rabbits.
[7] Wang's tendon stem cell research has focused on the effects of different mechanical loading conditions on TSC growth and differentiation.
[8] Focusing on TSCs, his work highlighted the role of TSC mechanobiology in tendon homeostasis as well as the development of degenerative tendinopathy.
His team demonstrated that the combined application of kartogenin and PRP effectively enhanced the formation of a fibrocartilage region connecting the tendon graft and bone interface, thereby improving the biomechanical strength of the tendon-bone junction.